vimarsana.com
Home
Live Updates
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients : comparemela.com
Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients
77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed...
Related Keywords
United States ,
United Kingdom ,
Philadelphia ,
Pennsylvania ,
New York ,
British ,
Karl Doghramji ,
Darren Opland ,
Mark Jacobson ,
Nasdaq ,
Axsome Therapeutics Inc ,
Narcolepsy Network ,
World Trade Center ,
Corporate Communications ,
Drug Administration ,
Epworth Sleepiness Scale ,
British Columbia Cognitive Complaints Inventory ,
Characterizing Patient Perspectives ,
Unmet Needs ,
Medical Director ,
Jefferson Sleep Disorders Center ,
Thomas Jefferson University ,
Topline Findings ,
Narcolepsy Symptoms While ,
Neutrality Statement ,
Axsome Therapeutics ,
comparemela.com © 2020. All Rights Reserved.